Antheia

Antheia

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://www.antheia.bio

Last Round

Series C

1/27/2026

Total Funding Raised

$380M

Momentum Score

25 /100

Company Overview

Antheia is a biotechnology company that develops cost-effective, plant-based medicines using synthetic biology, informatics, and fermentation technology to create active pharmaceutical ingredients from beneficial plant molecules for healthier patient care.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

synthetic biologysynbiobiomanufacturingactive pharmaceutical ingredientsAPIkey starting materialsKSMpharma supply chaindrug shortagesengineered yeastonshoring manufacturingThebaineNarcan ingredientfermentationbiosynthetic ingredientsCDMO partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antheia Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Antheia Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C1/27/2026
Series C6/3/2025
Grant12/3/2024
Strategic7/19/2024
Series C1/24/2024
Debt
6/22/2022

Key People

Founding team and executive leadership

Christina Smolke

CEO Co-Founder

Founding Team

Eric d'Esparbes

Chief Financial Officer

Executive Team

Zack McGahey

Chief Operating Officer

Executive Team

Antheia Investors

Notable investors and investment history

InvestorRounds
Sherpalo VenturesSeries C, Series B
America's Frontier FundSeries C
Athos KGSeries C
EDBISeries C
S-Cubed CapitalSeries C
HillspireSeries B
Viking Global InvestorsSeries C, Strategic, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    $80M Series C round completed.

  • Oct 21, 2025

    Eric d'Esparbes appointed as Chief Financial Officer.

Antheia Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Antheia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antheia's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range65
Year Founded2013
Last Funding1/27/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.